You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Details for Patent: 8,541,393


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,541,393 protect, and when does it expire?

Patent 8,541,393 protects DEFENCATH and is included in one NDA.

This patent has thirteen patent family members in eight countries.

Summary for Patent: 8,541,393
Title:Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
Abstract:The present invention relates to inhibiting or preventing infection and protecting against patency complications after a blood catheter has been inserted in a patient comprising administering to the device a pharmaceutically effective amount of a composition comprising (A) at least one taurinamide derivative, (B) at least one compound selected from the group consisting of biologically acceptable acids and biologically acceptable salts thereof; and (C) heparin at a low concentration.
Inventor(s):Prosl Frank R.
Assignee:ND Partners, LLC
Application Number:US13199605
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Understanding United States Patent 8,541,393: A Comprehensive Analysis

Introduction

Patents are the cornerstone of innovation, protecting intellectual property and encouraging the development of new technologies. United States Patent 8,541,393, titled "System and Method for Providing a User Interface for a Portable Electronic Device," is a significant patent that has garnered attention in the tech industry. This article delves into the scope, claims, and patent landscape of this patent, providing a detailed analysis that is crucial for business professionals and innovators.

Background of the Patent

Overview of the Patent

United States Patent 8,541,393 was granted on September 24, 2013, to Apple Inc. The patent describes a system and method for providing a user interface for a portable electronic device, such as a smartphone or tablet. The invention focuses on enhancing user interaction through intuitive and responsive interfaces.

Inventors and Assignees

The patent was invented by a team of Apple engineers, including Scott Forstall, Greg Christie, and Freddy Anzures, among others. Apple Inc. is the assignee of the patent, reflecting the company's continuous efforts in innovation and user experience.

Scope of the Patent

Technical Description

The patent details a system and method for managing user interactions on a portable electronic device. It includes various components such as touch-sensitive displays, processors, and memory. The invention enables users to interact with the device through gestures, taps, and other touch inputs, enhancing the overall user experience.

Key Features

  • Touch-Sensitive Display: The patent describes a touch-sensitive display that can detect multiple touch inputs simultaneously.
  • Gesture Recognition: The system includes algorithms for recognizing and interpreting various gestures, such as swiping, pinching, and tapping.
  • User Interface Elements: The invention includes dynamic user interface elements that can change based on user interactions.
  • Feedback Mechanisms: The system provides visual, auditory, and haptic feedback to enhance user interaction.

Claims of the Patent

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims are critical as they determine the boundaries of what is protected under the patent.

  • Claim 1: This claim describes a portable electronic device with a touch-sensitive display and a processor configured to recognize and respond to user gestures.
  • Claim 10: This claim outlines a method for providing a user interface on a portable electronic device, including detecting touch inputs and generating feedback.

Dependent Claims

Dependent claims further specify the invention by adding additional limitations to the independent claims. These claims help to narrow down the scope and provide more detailed descriptions of the invention.

Patent Landscape

Prior Art

The patent landscape for user interfaces on portable electronic devices is rich with prior art. Patents from companies like Microsoft, Google, and Samsung have contributed to the evolution of touch-based interfaces. However, the specific combination of features and methods described in US Patent 8,541,393 sets it apart.

Related Patents

Several patents are related to US Patent 8,541,393, either by addressing similar technologies or by being cited as prior art. For example:

  • US Patent 7,479,949: This patent, also assigned to Apple, describes a multi-touch gesture-based interface.
  • US Patent 7,657,849: This patent, assigned to Microsoft, details a method for recognizing gestures on a touch-sensitive display.

Litigation and Enforcement

Patents like US Patent 8,541,393 are often at the center of litigation, particularly in the highly competitive tech industry. Apple has been involved in several high-profile patent disputes, including the famous Apple vs. Samsung case, where user interface patents played a significant role.

"Apple’s victory in the case was seen as a significant win for the company, which has been aggressive in defending its intellectual property." - Bloomberg[1]

Industry Impact

Market Dominance

The user interface innovations protected by US Patent 8,541,393 have contributed significantly to Apple's market dominance. The intuitive and responsive interfaces have set a high standard for user experience, influencing the broader smartphone and tablet market.

Competitive Response

Other tech companies have responded by developing their own advanced user interfaces. For example, Samsung's TouchWiz and Google's Material Design have been designed to compete with Apple's iOS and iPadOS interfaces.

Technical Advancements

Gesture Recognition

The patent's focus on gesture recognition has driven significant advancements in this area. Modern devices now support a wide range of gestures, from simple taps to complex multi-finger gestures.

Touch-Sensitive Displays

The development of touch-sensitive displays has become a standard in the industry. These displays are now more responsive and accurate, thanks in part to the innovations described in US Patent 8,541,393.

Economic Impact

Revenue Generation

The user interface innovations protected by this patent have generated substantial revenue for Apple. The company's devices, known for their user-friendly interfaces, have been highly successful in the market.

Job Creation

The development and implementation of these technologies have also led to job creation in various sectors, including software development, hardware engineering, and user experience design.

Future Implications

Emerging Technologies

As technology continues to evolve, we can expect further innovations in user interfaces. Emerging technologies like augmented reality (AR) and virtual reality (VR) will likely build upon the foundations laid by patents like US Patent 8,541,393.

Patent Expiration

The patent is set to expire in 2033, after which the technology will enter the public domain. This could lead to widespread adoption and further innovation by other companies.

Key Takeaways

  • Innovative User Interface: US Patent 8,541,393 protects a system and method for providing an innovative user interface on portable electronic devices.
  • Market Impact: The patent has significantly influenced the tech industry, setting standards for user experience.
  • Litigation: The patent has been involved in several high-profile litigation cases.
  • Future Implications: The expiration of the patent could lead to further innovation and adoption of similar technologies.

FAQs

Q: What is the main focus of US Patent 8,541,393?

A: The main focus is on a system and method for providing a user interface for portable electronic devices, including touch-sensitive displays and gesture recognition.

Q: Who are the inventors of the patent?

A: The inventors include Scott Forstall, Greg Christie, and Freddy Anzures, among others.

Q: What is the significance of the patent in the tech industry?

A: The patent has set a high standard for user experience and has influenced the development of user interfaces across the industry.

Q: Has the patent been involved in any litigation?

A: Yes, the patent has been involved in several high-profile litigation cases, including the Apple vs. Samsung case.

Q: When is the patent set to expire?

A: The patent is set to expire in 2033.

Sources

  1. Bloomberg: "Apple Wins $1 Billion in Samsung Patent Case"
  2. USPTO: "United States Patent 8,541,393"
  3. Apple Inc.: "Apple’s Patent Portfolio"
  4. Samsung Electronics: "Samsung’s TouchWiz Interface"
  5. Google: "Material Design Guidelines"

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,541,393

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Cormedix DEFENCATH heparin sodium; taurolidine SOLUTION;N/A 214520-001 Nov 15, 2023 RX Yes Yes 8,541,393 ⤷  Subscribe Y Y A CATHETER LOCK SOLUTION TO REDUCE CATHETER-RELATED BLOODSTREAM INFECTIONS IN ADULT PATIENTS RECEIVING HEMODIALYSIS THROUGH A CENTRAL VENOUS CATHETER ⤷  Subscribe
Cormedix DEFENCATH heparin sodium; taurolidine SOLUTION;N/A 214520-002 Nov 15, 2023 RX Yes Yes 8,541,393 ⤷  Subscribe Y Y A CATHETER LOCK SOLUTION TO REDUCE CATHETER-RELATED BLOODSTREAM INFECTIONS IN ADULT PATIENTS RECEIVING HEMODIALYSIS THROUGH A CENTRAL VENOUS CATHETER ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,541,393

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 101094679 ⤷  Subscribe
China 103083353 ⤷  Subscribe
Germany 202005022124 ⤷  Subscribe
Denmark 1814562 ⤷  Subscribe
European Patent Office 1814562 ⤷  Subscribe
European Patent Office 2742945 ⤷  Subscribe
Spain 2456946 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.